“…Alternatively, several methods have been described in the literature for the determination of CNZ in its pharmaceutical dosage forms or in biological samples. Examples of these methods are various spectrophotometric and/or chemometric spectrophotometric methods (El-Gindy et al, 2004;Metwally et al, 2005;Gazy et al, 2006;El-Bardicy et al, 2008;Abdelrahman, 2013), synchronous fluorescence spectroscopy , chemiluminescence using flow-injection analysis (Townshend et al, 2003), voltammetry Hegde et al, 2009), potentiometric membrane sensors (Hassan et al, 1996), HPLC with UV detection (El-Gindy et al, 2004;Metwally et al, 2005;Heda et al, 2010;Navaneethan et al, 2013), HPLC with fluorescence detection (Angelov and Christova-Bagdassarian, 2003;Nowacka-Krukowska et al, 2007) and capillary electrophoresis . Few articles reported the HPTLC determination of pharmaceutical mixtures containing CNZ with piracetam (Metwally et al, 2005) and domperidone (Argekar and Powar, 1999;Bagade et al, 2005;Vinodhini et al, 2005).…”